CAS: 150812-12-7 - Retigabine
Formula:C16H18FN3O2
InChI:InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)
InChI key:InChIKey=PCOBBVZJEWWZFR-UHFFFAOYSA-N
SMILES:O=C(OCC)NC1=CC=C(C=C1N)NCC2=CC=C(F)C=C2
- Sinonimi:
- 2-Amino-4-(4-Fluorbenzylamino)-1-Ethoxycarbonylaminobenzene
- Carbamic acid, N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester
- Carbamic acid, [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester
- D 23129
- D2312
- Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate
- Ethyl {2-Amino-4-[(4-Fluorobenzyl)Amino]Phenyl}Carbamate
- Ezogabine
- Gke 841
- Gw 582892X
- Vedi altri sinonimi
- N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic Acid Ethyl Ester
- Potiga
- Retigabin
- RetigabineDiscontinued See: R189051
- Trobalt
- Way 143841
- [2-Amino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
Retigabine REF: 7W-GP5601CAS: 150812-12-7 | ≥ 98.0% | 139,00 €~459,00 € | Lun 02 Dic 24 | |
Retigabine REF: TR-R189050CAS: 150812-12-7 | - - - | 229,00 €~994,00 € | Mer 11 Dic 24 | |
Retigabine REF: 3D-FA61501CAS: 150812-12-7 | Min. 98 Area-% | 136,00 €~530,00 € | Gio 12 Dic 24 |
Retigabine
Ref: 7W-GP5601
10mg | 139,00 € | ||
25mg | 220,00 € | ||
100mg | 459,00 € |
Retigabine
Prodotto ControllatoRef: TR-R189050
10mg | 229,00 € | ||
50mg | 363,00 € | ||
250mg | 994,00 € |
Retigabine
Prodotto ControllatoRef: 3D-FA61501
1g | 352,00 € | ||
2g | 530,00 € | ||
100mg | 136,00 € | ||
250mg | 188,00 € | ||
500mg | 281,00 € |